Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoadsorption or Plasma Exchange - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

NCT04687332 is registered in ClinicalTrials.gov with University Medical Center Mainz as lead sponsor.

NCT NCT04687332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04687332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoadsorption or Plasma Exchange - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases
Lead sponsor
University Medical Center Mainz
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2016
Completion date
December 1, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurological autoimmune diseases